ALC vs EYE

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

ALC

ALCIDION FPO [ALC]

54MEDIUM

EYE

NOVA EYE FPO [EYE]

54MEDIUM

Score Breakdown

ALC EYE
Technical
43
41
Catalyst
50
50
Sentiment
50
50
Fundamental
87
63
Momentum
72
60
Risk Gate
50
45

Key Metrics

ALC Metric EYE
$137.0MMarket Cap$35.6M
1.6MAvg Volume (20d)340K
N/AShort InterestN/A
$0.14552-Week High$0.205
$0.06152-Week Low$0.086
+1.0%Daily Change+4.0%
$0.100Entry Price$0.130
+4.4%ROE-42.4%
+8.0%Profit Margin-21.3%

Active Signals

ALC Signals

Stochastic just turned bullish from a low level — early reversal sign
Trading below both moving averages — the trend is working against this one
Drifting lower — down 4.8% over the last 5 days
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (2.8x)
Strong revenue growth (+44%)
Piotroski F-Score strong (7/9, low-confidence approx)

EYE Signals

RSI drifting toward oversold territory — worth watching
Trading below both moving averages — the trend is working against this one
Drifting lower — down 3.7% over the last 5 days
Below the 200-day average — the long-term trend is still working against it
Low cash runway (2 quarters) - dilution risk
Low P/S ratio (1.1x)
Strong revenue growth (+29%)
EPS estimates revised upward (+10pts)

Ask Scout AI to compare ALC and EYE in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
ALC Full Analysis → EYE Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).